SARTORELLO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.670
AS - Asia 246
EU - Europa 209
AF - Africa 1
OC - Oceania 1
Totale 2.127
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.667
CN - Cina 116
SG - Singapore 70
VN - Vietnam 51
SE - Svezia 37
IT - Italia 34
FI - Finlandia 32
GB - Regno Unito 30
DE - Germania 21
FR - Francia 17
NL - Olanda 12
UA - Ucraina 11
BE - Belgio 4
CA - Canada 3
ES - Italia 3
IE - Irlanda 3
IN - India 3
AT - Austria 2
JP - Giappone 2
RO - Romania 2
TR - Turchia 2
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PH - Filippine 1
UG - Uganda 1
Totale 2.127
Salva come PNG Salva come JPEG
Città #
Fairfield 307
Ashburn 156
Chandler 154
Houston 128
Cambridge 115
Woodbridge 114
Seattle 104
Ann Arbor 84
Wilmington 76
Jacksonville 56
Dong Ket 50
Singapore 48
Princeton 40
Boardman 35
Beijing 26
San Diego 25
Nanjing 17
Medford 16
Washington 15
Santa Clara 14
Padova 12
Roxbury 12
Helsinki 10
New York 8
Changsha 7
Dallas 6
Des Moines 6
Hebei 6
Shenyang 6
Hefei 5
London 5
Borås 4
Los Angeles 4
Milan 4
Norwalk 4
Waanrode 4
Dublin 3
Florence 3
Kharkiv 3
Madrid 3
Redwood City 3
Tianjin 3
Tivoli 3
Frankfurt am Main 2
Guangzhou 2
Indiana 2
Istanbul 2
Pune 2
Shanghai 2
Auckland 1
Budapest 1
Cormeilles-en-Parisis 1
Dalian 1
Dearborn 1
Delhi 1
Edinburgh 1
Jiangmen 1
Kampala 1
Kilburn 1
Malo 1
Manila 1
Ningbo 1
Rockville 1
Shenzhen 1
Simi Valley 1
Southwark 1
Stockholm 1
Taiyuan 1
Tokyo 1
Tolbert 1
Toronto 1
Trento 1
Vienna 1
Vientiane 1
Totale 1.741
Salva come PNG Salva come JPEG
Nome #
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 121
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 118
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 109
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 103
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 97
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 95
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 95
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 94
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 89
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 85
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 84
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 84
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 80
Which assay is the most suitable to investigate von Willebrand factor functional activity? 79
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 78
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 77
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 77
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 75
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 74
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 71
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 69
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 64
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 64
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 48
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 42
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 37
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 28
Totale 2.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.612
article - articoli 8.417
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 47 28 42 54 48 28 21 17
2020/2021299 13 12 4 32 12 30 13 28 37 17 26 75
2021/2022364 16 29 70 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025185 1 50 42 36 56 0 0 0 0 0 0 0
Totale 2.137